Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome.

Roberts ME, Riegert-Johnson DL, Thomas BC, Rumilla KM, Thomas CS, Heckman MG, Purcell JU, Hanson NB, Leppig KA, Lim J, Cappel MA.

Genet Med. 2014 Sep;16(9):711-6. doi: 10.1038/gim.2014.19. Epub 2014 Mar 6.

PMID:
24603434
2.

Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.

Ponti G, Manfredini M, Tomasi A, Pellacani G.

Gene. 2016 Sep 10;589(2):127-32. doi: 10.1016/j.gene.2015.06.078. Epub 2015 Jul 2. Review.

PMID:
26143115
3.

Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.

Ponti G, Meschieri A, Pollio A, Ruini C, Manfredini M, Longo C, Mandel VD, Ciardo S, Tomasi A, Giannetti L, Pellacani G.

J Oral Pathol Med. 2015 Aug;44(7):552-7. doi: 10.1111/jop.12256. Epub 2014 Sep 12.

PMID:
25213213
4.

[The tip of the iceberg: multiple cutaneous sebaceous tumor in colon cancer. Muir-Torre syndrome--case report].

Herr G, Szenes M, Hohl G, Vinkler ME, Tüske G, Horváth J, Nagy G, Tihanyi M, Széll M, Nagy N, Gasztonyi B.

Orv Hetil. 2015 Jun 14;156(24):979-84. doi: 10.1556/650.2015.30165. Hungarian.

PMID:
26051134
5.

The frequency of Muir-Torre syndrome among Lynch syndrome families.

South CD, Hampel H, Comeras I, Westman JA, Frankel WL, de la Chapelle A.

J Natl Cancer Inst. 2008 Feb 20;100(4):277-81. doi: 10.1093/jnci/djm291. Epub 2008 Feb 12.

PMID:
18270343
6.

Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.

Neelakantan IV, Di Palma S, Smith CE, McCoombe A.

Head Neck Pathol. 2016 Sep;10(3):354-61. doi: 10.1007/s12105-015-0670-9. Epub 2015 Nov 17. Review.

7.

Muir-Torre syndrome: case report and review of the literature.

Ang JM, Alai NN, Ritter KR, Machtinger LA.

Cutis. 2011 Mar;87(3):125-8.

PMID:
21488569
8.

Muir-Torre syndrome-associated pleomorphic liposarcoma arising in a previous radiation field.

Yozu M, Symmans P, Dray M, Griffin J, Han C, Ng D, Parry S, Wong K.

Virchows Arch. 2013 Mar;462(3):355-60. doi: 10.1007/s00428-012-1369-x. Epub 2013 Jan 9.

PMID:
23299928
9.

[Case report: Muir-Torre syndrome diagnosed from a sebaceoma mimicking an ulcerated breast cancer].

Demolin G, Romain M, Münschke A, Vandingenen T, Blaude MA, Van Craynest MP.

J Gynecol Obstet Biol Reprod (Paris). 2016 Sep;45(7):767-74. doi: 10.1016/j.jgyn.2015.06.030. Epub 2015 Aug 28. French.

PMID:
26321614
10.

[Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].

Mercader P, García-Melgares ML, Roche E, Sánchez-Carazo JL, Alegre-de Miquel V.

Actas Dermosifiliogr. 2008 Sep;99(7):532-9. Spanish.

PMID:
18682166
11.

Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.

Archer-Dubon C, Alvarez-Zavala B, Reyes E, Orozco-Topete R.

Dermatol Online J. 2008 Dec 15;14(12):1.

12.

[Muir-Torre syndrome with previously undescribed frameshift mutation in the MSH2 gene].

Gilly B, Unholzer A, Strobl-Wildemann G, Haas C, Starz H, Welzel J.

Hautarzt. 2013 Apr;64(4):290-4. doi: 10.1007/s00105-012-2503-z. German.

PMID:
23229822
13.

Genitourinary tumors in men with the Muir-Torre syndrome.

Davis DA, Cohen PR.

J Am Acad Dermatol. 1995 Nov;33(5 Pt 2):909-12.

PMID:
7593809
14.

Is a cystic sebaceous neoplasm always marker for Muir-Torre syndrome?

Arsenovic N, Ramaiya A.

Dermatol Online J. 2009 Nov 15;15(11):11.

PMID:
19951647
15.

MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome.

Chhibber V, Dresser K, Mahalingam M.

Mod Pathol. 2008 Feb;21(2):159-64. Epub 2007 Dec 7.

16.

Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms.

Roberts ME, Riegert-Johnson DL, Thomas BC, Thomas CS, Heckman MG, Krishna M, DiCaudo DJ, Bridges AG, Hunt KS, Rumilla KM, Cappel MA.

J Genet Couns. 2013 Jun;22(3):393-405. doi: 10.1007/s10897-012-9552-4. Epub 2012 Dec 6.

PMID:
23212176
17.

MSH6 mutation in a family affected by Muir-Torre syndrome.

Kacerovska D, Cerna K, Martinek P, Grossmann P, Michal M, Ricar J, Kazakov DV.

Am J Dermatopathol. 2012 Aug;34(6):648-52. doi: 10.1097/DAD.0b013e3182446fe2.

PMID:
22814321
18.

A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome.

Perera S, Ramyar L, Mitri A, Pollett A, Gallinger S, Speevak MD, Aronson M, Bapat B.

J Hum Genet. 2010 Jan;55(1):37-41. doi: 10.1038/jhg.2009.119. Epub 2009 Nov 13.

PMID:
19911012
19.

[Muir-Torre syndrome associated with Waldenstrom's macroglobulinemia].

Velter C, Bourlond F, Wettle C, Lioure B, Lipsker D, Maugard C, Cribier B.

Ann Dermatol Venereol. 2016 Dec;143(12):825-830. doi: 10.1016/j.annder.2016.09.040. Epub 2016 Oct 19. French.

PMID:
27771121
20.

[Female patient with Muir-Torre syndrome].

Negraszus N, Jöhrens K, Bertelmann E.

Ophthalmologe. 2010 Nov;107(11):1059-62. doi: 10.1007/s00347-010-2165-0. German.

PMID:
20393721

Supplemental Content

Support Center